These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 23423530)
41. Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression. Ohl K; Tenbrock K Front Immunol; 2018; 9():2499. PubMed ID: 30425715 [TBL] [Abstract][Full Text] [Related]
42. Myeloid-derived suppressor cells are essential for maintaining feto-maternal immunotolerance via STAT3 signaling in mice. Pan T; Liu Y; Zhong LM; Shi MH; Duan XB; Wu K; Yang Q; Liu C; Wei JY; Ma XR; Shi K; Zhang H; Zhou J J Leukoc Biol; 2016 Sep; 100(3):499-511. PubMed ID: 27203698 [TBL] [Abstract][Full Text] [Related]
44. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells. Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951 [TBL] [Abstract][Full Text] [Related]
45. Myeloid-Derived Suppressor Cells in Fresno M; Gironès N Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737 [TBL] [Abstract][Full Text] [Related]
46. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway. Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139 [TBL] [Abstract][Full Text] [Related]
47. Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis. Malengier-Devlies B; Metzemaekers M; Wouters C; Proost P; Matthys P Front Immunol; 2021; 12():766620. PubMed ID: 34966386 [TBL] [Abstract][Full Text] [Related]
48. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients. Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623 [TBL] [Abstract][Full Text] [Related]
49. Autophagy regulates accumulation and functional activity of granulocytic myeloid-derived suppressor cells via STAT3 signaling in endotoxin shock. Dong G; Si C; Zhang Q; Yan F; Li C; Zhang H; Ma Q; Dai J; Li Z; Shi H; Wang B; Zhang J; Ming J; Hu Y; Geng S; Zhang Y; Li L; Xiong H Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2796-2807. PubMed ID: 28802852 [TBL] [Abstract][Full Text] [Related]
50. CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function. Choi J; Suh B; Ahn YO; Kim TM; Lee JO; Lee SH; Heo DS Tumour Biol; 2012 Feb; 33(1):121-9. PubMed ID: 22081309 [TBL] [Abstract][Full Text] [Related]
51. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. Parker KH; Beury DW; Ostrand-Rosenberg S Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631 [TBL] [Abstract][Full Text] [Related]
52. Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease. Bartneck M; Wang J Front Immunol; 2019; 10():2257. PubMed ID: 31616430 [TBL] [Abstract][Full Text] [Related]
53. Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity. Kramer ED; Abrams SI Front Immunol; 2020; 11():1963. PubMed ID: 32983128 [TBL] [Abstract][Full Text] [Related]
54. IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer. Yang Q; Li X; Chen H; Cao Y; Xiao Q; He Y; Wei J; Zhou J Oncogene; 2017 May; 36(21):2969-2980. PubMed ID: 28092673 [TBL] [Abstract][Full Text] [Related]
55. Myeloid-derived suppressor cells: paradoxical roles in infection and immunity. Dai J; El Gazzar M; Li GY; Moorman JP; Yao ZQ J Innate Immun; 2015; 7(2):116-26. PubMed ID: 25401944 [TBL] [Abstract][Full Text] [Related]
56. Myeloid-derived suppressor cells participate in preventing graft rejection. Wang Y; Gu X; Xiang J; Chen Z Clin Dev Immunol; 2012; 2012():731486. PubMed ID: 22481970 [TBL] [Abstract][Full Text] [Related]
57. Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice. Kawano T; Shimamura M; Nakagami H; Kanki H; Sasaki T; Mochizuki H PLoS One; 2019; 14(5):e0215482. PubMed ID: 31048856 [TBL] [Abstract][Full Text] [Related]
58. Myeloid-derived suppressor cells as effectors of immune suppression in cancer. Pyzer AR; Cole L; Rosenblatt J; Avigan DE Int J Cancer; 2016 Nov; 139(9):1915-26. PubMed ID: 27299510 [TBL] [Abstract][Full Text] [Related]